Cancer, Covid-19 and the perspective of treatments.
نویسندگان
چکیده مقاله:
Covid-19 pandemic had global effects on chronic patients, health systems, and the future of treatments. Among the chronic patients, people who have cancer are identifying as a vulnerable group because of their malignancy and suppressive treatments which weaken their immune system. The present descriptive-analytic article, which is conducted from studying various recent articles in Persian and English databases using the keywords cancer, coronavirus, digital treatments, diagnosis, screening, and cancer treatment, focuses on the perception of cancer patients from a covid-19 pandemic, the status of screening and diagnostic tests and the future perspective of health systems from 2019 to 2020. Cancer patients’ approach toward pandemics is on a spectrum, from anxiety and depression to feeling of peace with control and self-efficacy. Furthermore, cancer associations report that the rate of screening has been significantly decreased while it can increase the risk of metastasis in upcoming decades. However, not all treatment postpones are dangerous. It is noteworthy that cancer patients are time-sensitive, hence the health system is better to consider digital and technological treatment alternatives to minimize the patient presence in medical centers. eHealth and telemedicine had significant progress after the coronavirus pandemic and facilitate the delivery of services for patients and professionals, while the public opinion is positive about it.
منابع مشابه
COVID-19: combining antiviral and anti-inflammatory treatments
The high affinity of baricitinib for the numb-associated kinase (NAK) family, its anti-inflammatory properties, with its advantageous pharmacokinetic properties, appear to make it a special case among the approved drugs. In addition, the potential for combination therapy with baracitinib is high, because of its low plasma protein binding and minimal interaction with CYP enzymes and drug transp...
متن کاملA brief review of the latest pharmacological treatments of COVID-19
New Coronavirus which is called 2019-Novel-Coronavirus (2019-nCoV) or Severe acute respiratory Syndrome-Coronavirus 2 (SARS-Cov-2) causes deadly pneumonia that first appeared in December 2019 in Wuhan city in China. This virus spreads over the world quickly and made several problems to the community and health care system. Several drugs have been tried to manage COVID-19; however, our knowledge...
متن کاملProposed pharmacological treatments for COVID-19: previously confirmed drugs
Background: The outbreak of severe acute respiratory syndrome coronavirus-2, also called COVID-19, first appeared in December 2019 in Wuhan, China. COVID-19 is an enveloped single-stranded RNA virus, which has affected more than 14 million people around the world and caused a high rate of mortality. It is notable that discovering new drugs and vaccines against SARS-CoV2 is time consuming. ...
متن کاملMental Health and Quality of Life of Breast Cancer Patients During the COVID-19 Pandemic
COVID-19 first broke out on December 17, 2019, in Wuhan, China, and was declared a worldwide pandemic on March 11, 2020, according to the World Health Organization. Studies have shown that the incidence and mortality rate of COVID-19 is affected by age and specific diseases. Breast cancer patients may be more vulnerable to COVID-19 because of having a weakened immune system. In addition, COVI...
متن کاملthe study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region
چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...
15 صفحه اولInvestigation of the drivers of abnormal behaviors from the perspective of health managers during the COVID-19 pandemic
Introduction: Considering the COVID-19 pandemic and its severe effects on life, there is no doubt that an analysis of the components and drivers of abnormal behaviors can facilitate the emergence of moral behaviors. Therefore, we conducted this study in order to investigate the drivers of abnormal behaviors from the perspective of health managers during the COVID-19 pandemic. Methods: This res...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ذخیره در منابع من قبلا به منابع من ذحیره شده{@ msg_add @}
عنوان ژورنال
دوره 10 شماره 4
صفحات 207- 218
تاریخ انتشار 2021-07
با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.
کلمات کلیدی برای این مقاله ارائه نشده است
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023